This upregulation could be meaningful to ALS pathogenesis because genetic deletion of NOS2 (64) and systemic pharmacological inhibition of NOS2 (86) extend the lifespan of non-conditional hSOD1-G93A tg mice. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.